Pharmacokinetic Study of Dexmedetomidine After Intra-Nasal and Buccal Dosing in Children

Completed · Phase 1

Conditions studied: Heart Diseases

In brief

This research study is a continuation of a previous DEX PK study. It is examining the absorption of Dexmedetomidine (DEX) in the blood when given orally and as a nasal spray. This study will help us determine the best dosing amount for children undergoing sedation or anesthesia with DEX.

Key facts

Study ID
NCT03668951
Run by
Children's Hospital Medical Center, Cincinnati
People needed
18
Starts
2018-08-20
Expected to finish
2022-05-03
Last updated by the study team
2023-02-08

Who can join

Age: 1 and older, up to 4. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.